|
1
|
Seago M, Hosking AM, Greenway HT and
Kelley B: Extraocular sebaceous carcinoma treated with Mohs
micrographic surgery-A 24-year retrospective review of tumor
characteristics and treatment outcomes. Dermatol Surg.
47:1195–1199. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sa HS, Rubin ML, Xu S, Ning J, Tetzlaff M,
Sagiv O, Kandl TJ and Esmaeli B: Prognostic factors for local
recurrence, metastasis and survival for sebaceous carcinoma of the
eyelid: Observations in 100 patients. Br J Ophthalmol. 103:980–984.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tripathi R, Chen Z, Li L and Bordeaux JS:
Incidence and survival of sebaceous carcinoma in the United States.
J Am Acad Dermatol. 75:1210–1215. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Muqit MM, Foot B, Walters SJ, Mudhar HS,
Roberts F and Rennie IG: Observational prospective cohort study of
patients with newly-diagnosed ocular sebaceous carcinoma. Br J
Ophthalmol. 97:47–51. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xu M, Chen Q, Luo Y, Chai P, He X, Huang
H, Tan J, Ye J and Zhou C: Recurrence in eyelid sebaceous
carcinoma: A multicentric study of 418 patients. Invest Ophthalmol
Vis Sci. 65:42024. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Timtim E, Barahimi B, Mawn LA and Sobel
RK: Sebaceous carcinoma masquerading as ocular mucous membrane
pemphigoid. Orbit. 43:531–534. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lu L, Zhang Y, Ge S, Wen H, Tang X, Zeng
JC, Wang L, Zeng Z, Rada G, Ávila C, et al: Evidence mapping and
overview of systematic reviews of the effects of acupuncture
therapies. BMJ Open. 12:e0568032022. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang C, Zhu L, Liu X, Jiang M, Tang Q, Xu
F, Lin T, Dong L and He Y: MicroRNA-3907 promotes the proliferation
and migration of sebaceous gland carcinoma of the eyelid by
targeting thrombospondin 1. Oncol Lett. 22:8332021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Corbella E, Fara C, Covarelli F, Porreca
V, Palmisano B, Mignogna G, Corsi A, Riminucci M, Maras B and
Mancone C: THBS1 and THBS2 enhance the in vitro proliferation,
adhesion, migration and invasion of intrahepatic cholangiocarcinoma
cells. Int J Mol Sci. 25:17822024. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kaur S, Bronson SM, Pal-Nath D, Miller TW,
Soto-Pantoja DR and Roberts DD: Functions of thrombospondin-1 in
the tumor microenvironment. Int J Mol Sci. 22:45702021. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cen J, Feng L, Ke H, Bao L, Li LZ, Tanaka
Y, Weng J and Su L: Exosomal thrombospondin-1 disrupts the
integrity of endothelial intercellular junctions to facilitate
breast cancer cell metastasis. Cancers (Basel). 11:19462019.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huang C, Zhou X, Li Z, Liu H, He Y, Ye G
and Huang K: Downregulation of thrombospondin-1 by DNA
hypermethylation is associated with tumor progression in laryngeal
squamous cell carcinoma. Mol Med Rep. 14:2489–2496. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Momin MY, Gaddam RR, Kravitz M, Gupta A
and Vikram A: The challenges and opportunities in the development
of microRNA therapeutics: A multidisciplinary viewpoint. Cells.
10:30972021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vergani-Junior CA, Moro RP, Pinto S,
De-Souza EA, Camara H, Braga DL, Tonon-da-Silva G, Knittel TL, Ruiz
GP, Ludwig RG, et al: An intricate network involving the argonaute
ALG-1 modulates organismal resistance to oxidative stress. Nat
Commun. 15:30702024. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Meier F, Brunner AD, Koch S, Koch H,
Lubeck M, Krause M, Goedecke N, Decker J, Kosinski T, Park MA, et
al: Online parallel accumulation-serial fragmentation (PASEF) with
a novel trapped ion mobility mass spectrometer. Mol Cell
Proteomics. 17:2534–2545. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Haymond A, Davis JB and Espina V:
Proteomics for cancer drug design. Expert Rev Proteomics.
16:647–664. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang W, Wang HT, Liu X, Zhu LM and Lin TT:
Proteomic analysis of meibomian gland carcinoma cells after
overexpression of thrombospondin 1. Zhonghua Yan Ke Za Zhi J
Ophthalmol (Chinese). 61:376–383. 2025.PubMed/NCBI
|
|
18
|
Szklarczyk D, Kirsch R, Koutrouli M,
Nastou K, Mehryary F, Hachilif R, Gable AL, Fang T, Doncheva NT,
Pyysalo S, et al: The STRING database in 2023: Protein-protein
association networks and functional enrichment analyses for any
sequenced genome of interest. Nucleic Acids Res. 51:D638–D646.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Brabletz T, Kalluri R, Nieto MA and
Weinberg RA: EMT in cancer. Nat Rev Cancer. 18:128–134. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jayaraj P, Ray D, Goel K, Singh A, Kant N
and Sen S: Molecular landscape of eyelid sebaceous gland carcinoma:
A comprehensive review. Indian J Ophthalmol. 72:1393–1403. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cicinelli MV and Kaliki S: Ocular
sebaceous gland carcinoma: an update of the literature. Int
Ophthalmol. 39:1187–1197. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vempuluru VS, Tanna V, Luthra A and Kaliki
S: Eyelid/periocular sebaceous gland carcinoma in 500 eyes:
Analysis based on 8th edition American joint cancer committee
classification. Am J Ophthalmol. 269:49–59. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dini F, Susini P, Nisi G, Cuomo R,
Grimaldi L, Massi D, Innocenti A, Doni L, Mazzini C, Santoro N and
De Giorgi V: Periocular sebaceous carcinoma: Updates in the
diagnosis, treatment, staging, and management. Int J Dermatol.
63:726–736. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee YT, Tan YJ and Oon CE: Molecular
targeted therapy: Treating cancer with specificity. Eur J
Pharmacol. 834:188–196. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lin F, Li Z, Hua Y and Lim YP: Proteomic
profiling predicts drug response to novel targeted anticancer
therapeutics. Expert Rev Proteomics. 13:411–420. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tan HT, Lee YH and Chung MC: Cancer
proteomics. Mass Spectrom Rev. 31:583–605. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Haga Y, Minegishi Y and Ueda K: Frontiers
in mass spectrometry-based clinical proteomics for cancer diagnosis
and treatment. Cancer Sci. 114:1783–1791. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Abbaszadeh Z, Cesmeli S and Biray Avci C:
Crucial players in glycolysis: Cancer progress. Gene.
726:1441582020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liao Z and Xie Z: Construction of a
disulfidptosis-related glycolysis gene risk model to predict the
prognosis and immune infiltration analysis of gastric
adenocarcinoma. Clin Transl Oncol. 26:2309–2322. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cao X, Shao Y, Meng P, Cao Z, Yan G, Yao
J, Zhou X, Liu C, Zhang L, Shu H and Lu H: Nascent proteome and
glycoproteome reveal the inhibition role of ALG1 in hepatocellular
carcinoma cell migration. Phenomics. 2:230–241. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu G, Wu X and Chen J: Identification and
validation of a glycolysis-related gene signature for depicting
clinical characteristics and its relationship with tumor immunity
in patients with colon cancer. Aging. 14:8700–8718. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Verstappe J and Berx G: A role for partial
epithelial-to-mesenchymal transition in enabling stemness in
homeostasis and cancer. Semin Cancer Boil. 90:15–28. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ramesh V, Brabletz T and Ceppi P:
Targeting EMT in cancer with Repurposed Metabolic Inhibitors.
Trends in cancer. 6:942–950. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fontana R, Mestre-Farrera A and Yang J:
Update on epithelial-mesenchymal plasticity in cancer progression.
Annu Rev Pathol. 19:133–156. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Perez-Riverol Y, Bai J, Bandla C,
García-Seisdedos D, Hewapathirana S, Kamatchinathan S, Kundu DJ,
Prakash A, Frericks-Zipper A, Eisenacher M, et al: The PRIDE
database resources in 2022: A hub for mass spectrometry-based
proteomics evidences. Nucleic Acids Res. 50:D543–D552. 2022.
View Article : Google Scholar : PubMed/NCBI
|
